May 15

FDA approves tovorafenib for most common form of childhood brain tumor

This decision from the federal agency marks the first FDA approval of a systemic therapy to treat patients with pediatric LGG with BRAF rearrangements, including fusions.

Comments

Molecular mapping of brain tumours leads to better treatments for children

Tracing cancer back to birth uncovers promising biomarkers for prevention, targeted treatment of childhood leukemia

CRISPR Plus Drug Treatment Makes Neuroblastoma Responsive to Immunotherapy

Colorectal cancer cases on the rise in kids

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

First-of-their-kind findings turn conventional wisdom about diffuse hemispheric glioma on its head

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

‘Alarmingly’ few childhood cancer survivors undergo recommended surveillance for late effects

Survivors of childhood brain cancer are more likely to be held back in school

Gene therapy for fatal child brain disease may cause blood cancers

Recent Posts

FDA approves tovorafenib for most common form of childhood brain tumor

Comments

Archive

Search By Tags